| DC Field | Value | Language |
|---|
| dc.contributor.author | Shcheblykin, D. V. | - |
| dc.contributor.author | Bolgov, A. A. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Stepenko, Yu. V. | - |
| dc.contributor.author | Tsuverkalova, Y. M. | - |
| dc.contributor.author | Shcheblykina, O. V. | - |
| dc.contributor.author | Korokina, L. V. | - |
| dc.date.accessioned | 2023-04-11T09:36:59Z | - |
| dc.date.available | 2023-04-11T09:36:59Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Endothelial dysfunction: developmental mechanisms and therapeutic strategies / D.V. Shcheblykin [et al.] // Research Results in Pharmacology. - 2022. - Vol.8, №4.-P. 115-139. - Doi: 10.3897/rrpharmacology.8.80376. - Refer.: p. 126-139. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/52731 | - |
| dc.description.abstract | Endothelial dysfunction is a typical pathological process involved in the pathogenesis of many diseases. Thus, pharmacological agents with endothelioprotective properties can provide more therapeutic benefits than a drug without such an effect | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelium | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | biomarkers | ru |
| dc.subject | therapeutic strategies | ru |
| dc.title | Endothelial dysfunction: developmental mechanisms and therapeutic strategies | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 8, № 4
|
